MRNA Apr 2024 100.000 call
| Previous close | 15.45 |
| Open | 15.68 |
| Bid | 16.50 |
| Ask | 16.80 |
| Strike | 100.00 |
| Expiry date | 2024-04-19 |
| Day's range | 15.68 - 15.68 |
| Contract range | N/A |
| Volume | |
| Open interest | 219 |
ZacksIs it Time to Buy Pfizer, Moderna, or AstraZeneca's Stock?
Despite slowing COVID-19 vaccine sales these healthcare titans are trading at more reasonable valuations with a lot of the risk-to-reward being priced into their stocks considering their earnings potential.
ZacksModerna (MRNA) Outpaces Stock Market Gains: What You Should Know
In the latest trading session, Moderna (MRNA) closed at $100.27, marking a +0.83% move from the previous day.
- Financial Times
EU in talks with Moderna over new vaccine supply deal
Brussels is negotiating a new Covid-19 vaccine procurement deal with US drugmaker Moderna as EU health authorities grow concerned about a rise in coronavirus infections. The deal is being negotiated between Brussels and the Boston-based biotechnology group, two people familiar with the matter said, with member states able to confirm their interest on an individual basis. At least eight EU countries were interested in opting into a new supply deal, one of the people said, adding that the contract was specifically for messenger ribonucleic acid-based Covid-19 vaccines.
